Inventor of 4-disease drug gets a boost thanks to ISRAEL21c

It was our third most popular article in 2018, and it’s not hard to understand why: “One drug could treat Alzheimer, MS, Crohn’s disease and more” captured the attention of readers around the world. “I received quite a high number of mails, mostly from patients or relatives of patients, for instance families of Alzheimer’s patients,” says Prof. David Naor of the Lautenberg Center for Immunology and Cancer Research at the Hebrew University of Jerusalem’s Faculty of Medicine.

Naor has spent more than a decade researching a peptide of five amino acids (called 5-MER) that neutralizes the pathological amyloid proteins associated with some incurable inflammatory and neuro degenerative diseases. The IP-protected peptide is being developed with the support of grants from the university’s Yissum technology-transfer company, the Israeli government, Spherium Biomed of Spain and Israeli pharmaceutical company Galmed. The four diseases Naor has been researching in connection with 5-MER– Alzheimer’s, Crohn’s, multiple sclerosis and rheumatoid arthritis — all share pathological amyloid proteins,which are targeted by the potential peptide drug, he tells ISRAEL21c. After our article was published on February 11, 2018, Naor received a $5,000 donation that he is using toward further research. “The donor’s wife suffers from Alzheimer’s disease,” he explains. The American donor told Naor that he hopes to make an additional contribution in the future.-- More...

---

---